WHO ICTRP trial
Improving wellbeing after acquired brain injury with a group program to enhance…
ACTRN12619001243101 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12619001243101 |
|---|---|
| Public title | Improving wellbeing after acquired brain injury with a group program to enhance participation in valued activities |
| Scientific title | Evaluation of a group-based intervention to enhance wellbeing after acquired brain injury: A Phase II randomised controlled trial of VaLiANT (Valued Living After Neurological Trauma) |
| Primary sponsor | La Trobe University |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Acquired Brain Injury;Epilepsy;Multiple sclerosis ; Acquired Brain Injury Epilepsy Multiple sclerosis ;Neurological - Other neurological disorders;Neurological - Epilepsy;Neurological - Multiple sclerosis;Injuries and Accidents - Other… |
| Interventions | The overarching aim of this study is to investigate the clinical effectiveness, feasibility and acceptability of the 8-week valued living program (VaLiANT) in acquired brain injury survivors. VaLiANT is a group therapy program that… |
| Registration date | Sep 9, 2019 |
| Target size | 75 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: